Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PON1 | P27169 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.40 |
| ▸ | GLA | P06280 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21533758 | 0.83 | KDM4E (0.45) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL24487124 | 0.78 | ALDH1A1 (0.43) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL21171750 | 0.66 | ACHE (0.48) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL25037449 | 0.65 | MAPT (0.47) | PON1GAAPOLBMTNR1AMEN1 | |
| SCHEMBL24820151 | 0.65 | NPC1 (0.42) | ALDH1A1KDM4EGAAPOLBHPGD | |
| SCHEMBL24487254 | 0.64 | NQO1 (0.43) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL3918098 | 0.64 | KCNA3 (0.57) | — | |
| SCHEMBL8359458 | 0.64 | PON1 (0.61) | PON1ALDH1A1KDM4EGLAGAA | |
| SCHEMBL21533787 | 0.63 | ALDH1A1 (0.51) | ALDH1A1HPGDKMT2ATDP1MAPT | |
| SCHEMBL21171772 | 0.63 | ALDH1A1 (0.42) | ALDH1A1KDM4EGAAHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170336368-A1 | METHODS FOR LIQUID CHROMATOGRAPHY CALIBRATION FOR RAPID LABELED N-GLYCANS | WATERS TECHNOLOGIES CORPORATION (US) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170336368-A1 | METHODS FOR LIQUID CHROMATOGRAPHY CALIBRATION FOR RAPID LABELED N-GLYCANS | DDOST, STT3B, CSGALNACT1 | PON1 4142/4885ALDH1A1 1045/4885KDM4E 2167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.